Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

BV-ICE - Brentuximab Vedotin 1.8 / Etoposide 100 / Carboplatin 5 / Ifosfamide 5, T-cell Lymphoma

Protocol-ID: 2420 V1.0 (Mini), BV-ICE (BRNT1.8/ETOP100/CRBP5/IFOS5), T-NHL

Indication(s)

  • NHL, T-cell type; ICD-10 C84.5
    CD30+
  • NHL, T-Cell Type, Adult T-Cell Leukemia or Lymphoma; ICD-10 C91.5-
    CD30+
  • NHL, T-Cell Type, Anaplastic Large Cell; ICD-10 C84.4
    CD30+
  • NHL, T-Cell Type, Anaplastic Large Cell Lymphoma, ALK negative; ICD-10 C84.7
    CD30+
  • NHL, T-Cell Type, Anaplastic Large Cell Lymphoma, ALK-positive; ICD-10 C84.6
    CD30+
  • NHL, T-Cell Type, Angioimmunoblastic; ICD-10 C86.5
    CD30+
  • NHL, T-Cell Type, Enteropathy Type; ICD-10 C86.2
    CD30+
  • NHL, T-Cell Type, Hepatosplenic; ICD-10 C86.1
    CD30+
  • NHL, T-Cell Type, Peripheral, Unspecified; ICD-10 C84.4
    CD30+
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 30.08.2023